Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc.

No trades
See on Supercharts
Market capitalization
‪448.27 M‬USD
−10.38USD
‪−44.60 M‬USD
‪10.38 M‬
Beta (1Y)
1.06

About Corbus Pharmaceuticals Holdings, Inc.

CEO
Yuval Cohen
Headquarters
Norwood
Employees (FY)
19
Founded
2009
ISIN
US21833P3010
FIGI
BBG0078PJKQ7
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where CRBP is featured.

Frequently Asked Questions

The current price of CRBP is 41.52 USD — it has decreased by 2.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Corbus Pharmaceuticals Holdings, Inc. stocks are traded under the ticker CRBP.
Corbus Pharmaceuticals Holdings, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Corbus Pharmaceuticals Holdings, Inc. has a max estimate of 58.00 USD and a min estimate of 52.00 USD.
CRBP earnings for the last quarter are −2.27 USD whereas the estimation was −2.06 USD which accounts for −10.19% surprise. Estimated earnings for the next quarter are −2.16 USD. See more details about Corbus Pharmaceuticals Holdings, Inc. earnings.
Corbus Pharmaceuticals Holdings, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪150.00 K‬ USD. In the next quarter revenue is expected to reach ‪200.00 K‬ USD.
Yes, you can track Corbus Pharmaceuticals Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CRBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Corbus Pharmaceuticals Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CRBP reached its all-time high on Oct 10, 2016 with the price of 323.40 USD, and its all-time low was 2.11 USD and was reached on Mar 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 19.00 employees. See our rating of the largest employees — is Corbus Pharmaceuticals Holdings, Inc. on this list?